Clinical Trial: A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in China
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Crohn Disease
Study Type: OBSERVATIONAL
Official Title: A Multicenter, Retrospective, Observational Study Using Real-world Data to Describe the Effectiveness, Treatment Pattern and Safety of Ustekinumab Among Bio-naive Patients With Crohn's Disease in
Brief Summary:
Bio-naive participants are defined as the participants who previously have not received any biologics for Crohn's Disease (CD).The purpose of this retrospective study is to describe the endoscopic remission at week 24 among bio-naive participants with CD treated with ustekinumab in China.
Read more